[Congressional Record Volume 161, Number 76 (Monday, May 18, 2015)]
[Senate]
[Page S3005]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
SA 1364. Mr. SANDERS submitted an amendment intended to be proposed
to amendment SA 1221 proposed by Mr. Hatch to the bill H.R. 1314, to
amend the Internal Revenue Code of 1986 to provide for a right to an
administrative appeal relating to adverse determinations of tax-exempt
status of certain organizations; which was ordered to lie on the table;
as follows:
At the appropriate place in title I, add the following:
SEC. 1___. DRUG IMPORTATION.
(a) Promulgation of Regulations.--The trade authorities
procedures shall not apply to an implementing bill submitted
with respect to a trade agreement or trade agreements entered
into under section 103(b) until the Secretary of Health and
Human Services promulgates regulations under section 804(b)
of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
384(b)), as amended by subsection (b)(2).
(b) Amendments to FFDCA.--Section 804 of the Federal Food,
Drug, and Cosmetic Act (21 U.S.C. 384) is amended--
(1) in subsection (a)(1), by striking ``pharmacist or
wholesaler'' and inserting ``pharmacist, wholesaler, or the
head of a relevant agency of the Federal Government'';
(2) in subsection (b), by striking ``from Canada'';
(3) in subsection (f), by striking ``Canada'' and inserting
`` any country that is a party to the Trans-Pacific
Partnership Agreement''; and
(4) in subsection (j)--
(A) in the heading of paragraph (3), by striking ``Canada''
and inserting ``a foreign country''; and
(B) in paragraph (3)(C), by striking ``from Canada'' and
inserting ``from a country that is a party to the Trans-
Pacific Partnership Agreement''.
(c) Prescription Drug Importation.--The principal
negotiating objective of the United States regarding the
importation of prescription drugs is to permit the
importation of such drugs from any country that is a party to
a trade agreement with the United States, pursuant to section
804 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
384).
______